Carl C. Crodel

Jena, TH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP).

Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP).

Journal: Annals of hematology

Published: April 16, 2026

Type I interferon-activated NK cells control polycythemia vera in vivo.

Type I interferon-activated NK cells control polycythemia vera in vivo.

Journal: Blood

Published: March 09, 2026

Dysregulation of HIF-1α-regulated and thromboinflammatory genes may contribute to thrombotic risk in patients with BCR::ABL1-negative myeloproliferative neoplasms.

Dysregulation of HIF-1α-regulated and thromboinflammatory genes may contribute to thrombotic risk in patients with BCR::ABL1-negative myeloproliferative neoplasms.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 28, 2025

Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression?

Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression?

Journal: Journal of cancer research and clinical oncology

Published: September 24, 2025

Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasias.

Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasias.

Journal: Journal of cancer research and clinical oncology

Published: June 23, 2025

Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis.

Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis.

Journal: Annals of hematology

Published: January 30, 2025

ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis.

ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis.

Journal: Blood advances

Published: January 09, 2025

Molecular and Clinical Risk Factors Associated with Thrombosis and Bleeding in Myelofibrosis Patients.

Molecular and Clinical Risk Factors Associated with Thrombosis and Bleeding in Myelofibrosis Patients.

Journal: Hamostaseologie

Published: December 21, 2024

Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN).

Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN).

Journal: Leukemia

Published: June 26, 2024

MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.

MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.

Journal: Annals of hematology

Published: May 20, 2024

Immunofluorescence microscopy on the blood smear identifies patients with myeloproliferative neoplasms.

Immunofluorescence microscopy on the blood smear identifies patients with myeloproliferative neoplasms.

Journal: Leukemia

Published: April 26, 2024

Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany.

Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany.

Journal: Journal of cancer research and clinical oncology

Published: February 17, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026